More needs to be done to get working therapies to the clinic.
In this presentation given at Ending Age-Related Diseases 2020, Dr. Isabelle Schiffer of the Forever Healthy Foundation discusses the state of rejuvenation therapies and progress in bringing them into clinical practice. She discusses the rejuvenation market along with senotherapies, which target senescent cells in order to treat age-related diseases. This presentation featured the dasatinib + quercetin senolytic combination along with the supplement fisetin. As she explains, the problems with senolytics as a clinical therapy, as things stand today, are that there are no treatment protocols and no clinical endpoints.
| HELP SPREAD THE WORD |
| Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: |
|
|
| Thank You! |
Write a comment: